Pharmaceutical giant Pfizer has opted to withdraw its pursuit of a mass tort designation concerning its contraceptive injection, Depo-Provera. The decision follows the dismissal of the majority of related lawsuits in the Philadelphia Court of Common Pleas.
Despite Pfizer’s initial expectations that many of the dismissed claimants would resubmit their cases, this has not materialized into significant legal action. Currently, only one lawsuit regarding Depo-Provera remains active in the Philadelphia jurisdiction. This development marks a significant step back for those seeking multiple plaintiffs’ action against the company.
For further details on this legal development, the original coverage can be accessed via The Legal Intelligencer.